• Maplight Therapeutics Chief Medical Officer Erin Pennock Foff sold 4,438 shares of voting common stock on May 7, 2026.
• Sales were executed at weighted average prices of USD 28.52 and USD 29.1.
• Holdings fell to 346,059 shares following transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maplight Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002021233-26-000010), on May 11, 2026, and is solely responsible for the information contained therein.